Workflow

AI / GxP Governance

AI-assisted pharmacovigilance and automated regulatory intelligence must meet GxP, validation, and human oversight expectations. Track FDA, EMA, and industry guidance on AI in drug safety, algorithm change control, audit trails, and governance models that keep signal detection and case processing inspection-ready.

2 updates · Sorted by impact priority

publicUpdated May 21, 2026

WSJ: Japan adds new warnings for Amgen’s Tavneos after deaths

Urgency: Medium

This update requires triage for Label Governance, Signal Validation, Risk Management; confirm local obligations and document follow-up actions.

Label GovernanceSignal ValidationSignal Management Lead

SOP Impact5 SOPs

ConfidenceMedium

Relevant for: Signal Management Lead, Labeling Lead, PV Technology / CSV Lead

verifiedRegulatory action: Latest

Read impact briefarrow_forward

publicEma · Updated May 21, 2026

MaaT Pharma flags CHMP “negative trend” ahead of June vote

Urgency: Medium

Ema update requires triage for Label Governance, Risk Management, AI / GxP Governance; confirm local obligations and document follow-up actions.

Label GovernanceRisk ManagementSignal Management Lead

SOP Impact5 SOPs

ConfidenceMedium

Relevant for: Signal Management Lead, Labeling Lead, Regulatory Intelligence Lead

verifiedRegulatory action: Latest

Read impact briefarrow_forward

Get updates for your PV role

Subscribe to impact-first pharmacovigilance updates. Select every role you want in your digest.

Digest roles: QPPV. Work email only · workflow AI / GxP Governance